SG11201510325XA - Methods for promoting neuronal development and/or health - Google Patents

Methods for promoting neuronal development and/or health

Info

Publication number
SG11201510325XA
SG11201510325XA SG11201510325XA SG11201510325XA SG11201510325XA SG 11201510325X A SG11201510325X A SG 11201510325XA SG 11201510325X A SG11201510325X A SG 11201510325XA SG 11201510325X A SG11201510325X A SG 11201510325XA SG 11201510325X A SG11201510325X A SG 11201510325XA
Authority
SG
Singapore
Prior art keywords
health
methods
neuronal development
promoting neuronal
promoting
Prior art date
Application number
SG11201510325XA
Inventor
Chenzhong Kuang
Yan Xiao
Eduard K Poels
Zeina Jouni
Dirk Hondmann
Original Assignee
Mjn Us Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mjn Us Holdings Llc filed Critical Mjn Us Holdings Llc
Publication of SG11201510325XA publication Critical patent/SG11201510325XA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/26—Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG11201510325XA 2013-07-16 2014-06-21 Methods for promoting neuronal development and/or health SG11201510325XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/942,794 US9241923B2 (en) 2013-07-16 2013-07-16 Methods for promoting neuronal development and/or health
PCT/US2014/043531 WO2015009406A1 (en) 2013-07-16 2014-06-21 Methods for promoting neuronal development and/or health

Publications (1)

Publication Number Publication Date
SG11201510325XA true SG11201510325XA (en) 2016-01-28

Family

ID=51211331

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201510325XA SG11201510325XA (en) 2013-07-16 2014-06-21 Methods for promoting neuronal development and/or health

Country Status (12)

Country Link
US (1) US9241923B2 (en)
EP (1) EP3027057A1 (en)
CN (1) CN105431056A (en)
AR (1) AR096941A1 (en)
AU (1) AU2014290766B2 (en)
CA (1) CA2918457A1 (en)
HK (1) HK1222771A1 (en)
MX (1) MX2016000422A (en)
PH (1) PH12016500082A1 (en)
SG (1) SG11201510325XA (en)
TW (1) TW201524505A (en)
WO (1) WO2015009406A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10525016B2 (en) * 2015-06-03 2020-01-07 Mead Johnson Nutrition Company Nutritional compositions containing an elevated level of inositol and uses thereof
CN107690332A (en) * 2015-06-11 2018-02-13 雀巢产品技术援助有限公司 Dietary supplements
ES2551053B1 (en) * 2015-07-31 2016-09-06 Fertypharm, S.L. Polyvitamin food supplement for pregnant women
CN110891982B (en) 2017-04-17 2023-12-22 芝加哥大学 Polymeric materials for delivering short chain fatty acids to the intestinal tract for human health and disease treatment
US11065288B2 (en) 2017-09-29 2021-07-20 Kinjirushi Co., Ltd. Neuron activator
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
MX2020006768A (en) 2017-12-29 2020-08-24 Kraft Foods Group Brands Llc Improved oxidative stability of oil-in-water emulsions using natural stabilizers.
CN108771669B (en) * 2018-05-31 2020-06-16 暨南大学 Application of sulforaphane in preparation of medicine for protecting fetus blood vessel development of women drinking wine during pregnancy

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
DK165090D0 (en) 1990-07-09 1990-07-09 Kem En Tec As CONLOMERATED PARTICLES
NZ241359A (en) 1991-01-24 1994-08-26 Martek Corp Supplementation of infant formula by the addition of at least two different polyunsaturated fatty acids obtained from at least two different microbial sources; compositions comprising such oils
US5374567A (en) 1993-05-20 1994-12-20 The United States Of America As Represented By The Secretary Of The Navy Operational amplifier using bipolar junction transistors in silicon-on-sapphire
EP1142484A2 (en) 1994-02-16 2001-10-10 Pharming Intellectual Property BV Isolation of lactoferrin from milk
SE9503926D0 (en) 1995-11-07 1995-11-07 Pharmacia Biotech Ab Adsorption process and separation medium
JPH10236975A (en) * 1997-02-21 1998-09-08 Morinaga Milk Ind Co Ltd Antioxidative composition
GB9715444D0 (en) 1997-07-22 1997-09-24 Scotia Holdings Plc Therapeutic and dietary compositions
US6620326B1 (en) 1998-06-18 2003-09-16 Upfront Chromatography A/S Expanded bed adsorption system
AU5823801A (en) 2000-05-12 2001-11-20 Upfront Chromatography As A bed adsorption system
US6332533B1 (en) 2000-08-29 2001-12-25 H.H.H. Incorprorated Media holder mouse pad
ATE290323T1 (en) 2001-06-01 2005-03-15 Upfront Chromatography As FRACTIONATION OF MIXTURES CONTAINING PROTEIN
DK1480524T3 (en) 2002-03-07 2013-07-15 Upfront Chromatography As Method for isolating lactoferrin
US20050107338A1 (en) 2003-11-17 2005-05-19 Seidman Michael D. Nutritional supplement enhancing mitochondrial function
CN101018561A (en) * 2004-07-19 2007-08-15 N·V·努特里奇亚 Preparation for use of aspartate and vitamin B12 or biotin for regulating ketone bodies
US8075934B2 (en) * 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
US8883814B2 (en) 2006-06-05 2014-11-11 Keyview Labs, Inc. Compositions and methods for enhancing brain function
US20080003330A1 (en) 2006-06-30 2008-01-03 Ricardo Rueda Infant formulas for early brain development
WO2009157759A1 (en) * 2008-06-23 2009-12-30 N.V. Nutricia Nutritional composition for improving the mammalian immune system
EP2251030A1 (en) * 2009-05-12 2010-11-17 Nestec S.A. Lactoferrin and brain health and development in infants
EP2258218A1 (en) 2009-06-02 2010-12-08 Nestec S.A. Nutritional Composition for Supporting Brain Development and Function of Toddlers
WO2011051482A1 (en) 2009-10-29 2011-05-05 Nestec S.A. Nutritional compositions comprising lactoferrin and probiotics and kits of parts thereof
US20130172286A1 (en) * 2010-03-31 2013-07-04 Vegenat, S.A. Functional Food Supplement Intended, In Particular, For Nutrition And For Prevention And Improvement of Neurological Alterations, Neurodegenerative Alterations Or Cognitive Disorders
US8968722B2 (en) 2010-12-29 2015-03-03 Mead Johnson Nutrition Company Milk-based nutritional compositions containing lactoferrin and uses thereof
WO2012170021A1 (en) * 2011-06-08 2012-12-13 Nestec S.A. Nutritional compositions having exogenous milk fat globule membrane components
WO2012177118A1 (en) * 2011-06-22 2012-12-27 N.V. Nutricia Method for reducing the occurrence of infection in young children
CN102318827B (en) 2011-07-15 2013-02-27 浙江康恩贝健康产品有限公司 Nutrient composition and health care product for promoting development of nervous system
EP2609814A1 (en) 2011-12-30 2013-07-03 Nestec S.A. Lactobacillus reuteri DSM 17938 for the development of cognitive function
US20140179775A1 (en) 2012-02-29 2014-06-26 Mead Johnson Nutrition Company Neurogenesis screening method and uses thereof
US20140199265A1 (en) 2013-01-11 2014-07-17 Mead Johnson Nutrition Company Nutritional compositions containing a neurologic component and uses thereof

Also Published As

Publication number Publication date
TW201524505A (en) 2015-07-01
HK1222771A1 (en) 2017-07-14
CN105431056A (en) 2016-03-23
CA2918457A1 (en) 2015-01-22
AU2014290766A1 (en) 2015-12-24
WO2015009406A1 (en) 2015-01-22
AU2014290766B2 (en) 2017-08-17
US9241923B2 (en) 2016-01-26
US20150023922A1 (en) 2015-01-22
EP3027057A1 (en) 2016-06-08
PH12016500082A1 (en) 2016-04-18
MX2016000422A (en) 2016-04-20
AR096941A1 (en) 2016-02-10

Similar Documents

Publication Publication Date Title
HK1222530A1 (en) Microclosures and related methods for skin treatment
HK1219642A1 (en) Opto-physiological sensor and method
GB201517905D0 (en) Learning health systems and methods
PL3046470T3 (en) Diagnosing and treating movement disorders
EP2959275A4 (en) Diagnostic instrument and method
GB201309568D0 (en) Methods and apparatus
EP2980007A4 (en) Filler-cleaning method and device
EP2948188A4 (en) Neuronal imaging and treatment
HK1222771A1 (en) Methods for promoting neuronal development and or health
GB201306633D0 (en) Biaising circuitry and method thereof
HK1215164A1 (en) Treatment methods
PL3084506T3 (en) Endoscope and method for using same
EP2957925A4 (en) Scattering tomography method and scattering tomography device
EP2952877A4 (en) Gas-barrier-performance evaluation device and evaluation method
HK1209671A1 (en) Aesthetic treatment device and method
EP2952876A4 (en) Gas-barrier-performance evaluation device and evaluation method
EP2946614A4 (en) Methods and apparatus
IL240812B (en) Unit and method for corona treatment
ZA201504763B (en) Surgical template arrangement and method
GB201604534D0 (en) Nucleic-acid-sequence determination device and nucleic-acid-sequence determination method
GB201301728D0 (en) Telcommunications apparatus and methods
GB201307787D0 (en) Methods and Apparatus
GB2519734B (en) Apparatus and Methods
GB201316737D0 (en) Apparatus and Methods
GB201310502D0 (en) Device and methods